Recruiting studies: Infection In An Immunocompromised Host

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
Phase 3 · 148 location(s) · Pfizer · NCT07013474 Third Party Viral Specific T-cells (VSTs)
Phase 2 · 4 location(s) · Children's Hospital Medical Center, Cincinnati · NCT02532452 Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
Phase 2 · 3 location(s) · Fred Hutchinson Cancer Center · NCT06817889 RSV Vaccination in Immunocompromised Patients.
Phase 2 · 1 location(s) · Medical University of Vienna · NCT06597916

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.